News
As a part of this deal, APL also acquired high profile OTC ... with China National Pharmaceutical Group Corporation (Sinopharm) to divest in its subsidiary company Aurobindo (Datong) Bio Pharma ...
Tata Midcap Growth Fund turns a Rs 1,000 monthly SIP into Rs 1 crore in 30 years. Explore its top holdings, risk profile, and ...
14d
Zacks Investment Research on MSNACAD Stock Soars as US Court Rules in Favor of Key Nuplazid PatentAcadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in ...
The urinary tract infection (UTI) treatment market is estimated to be valued at USD 11.24 billion in 2024. The scope for urinary tract infection (UTI) treatment is predicted to rise at a CAGR of 1.9% ...
Aurobindo Pharma's stock experienced a price fall during today's trading session. The stock is currently trading at Rs 1,167.10, reflecting a decrease of 2.02%. This movement places Aurobindo ...
Shares of Aurobindo Pharma Ltd fell 2.5 percent to Rs 1,161 in morning trade on May 28 after the company reported an 11 percent increase in revenue and a marginal drop in net profit in the March ...
On a fiscal year basis (FY25), Aurobindo Pharma’s PAT increased 10% y-o-y to ₹3,484 crore from ₹3,169 crore in FY24, showing better full year profitability. Annual income at the company ...
GIC Re on Monday posted a 17% decline in net profit to ₹2,183 crore for the fourth quarter ended March 2025. The state-owned ...
Aurobindo Pharma, through its wholly owned subsidiary Apitoria, launched ‘Auro Astra’ a leadership development initiative in collaboration with the Institute of Management Technology ...
Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o ... of the European Medicines Agency (EMA), the company had said the product is intended for the treatment of neutropenia and the mobilisation ...
4d
Capital Market on MSNAurobindo Pharma arm incorporates WOS in NetherlandsThe purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.
On the stocks to buy front, Sachin Gupta recommends Aurobindo Pharma Ltd, and Bharat Dynamics Ltd. Here's what Gupta says about the stock market. Nifty 50 rose by 0.5% today, driven primarily by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results